Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Greco

Showing results (201-210 of 313) with videos related to

Pageof 32
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1982
Effects of high-dose cytarabineK R Hande, R S Stein, D A McDonough, et al.
Cancer Treatment Reports|May 1, 1985
Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lungL L Porter, D H Johnson, J D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II studyD S Thompson, J D Hainsworth, K R Hande, et al.
Cancer Treatment Reports|October 1, 1983
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lungS N Wolff, D H Johnson, K R Hande, et al.
The American Journal of Medicine|September 1, 1982
Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancerK R Hande, R K Oldham, M F Fer, et al.
Cancer Treatment Reports|March 1, 1981
Combination of vinblastine and bleomycin in metastatic renal cell carcinomaJ A Knost, R K Oldham, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposideJ D Hainsworth, J B Erland, L A Kalman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Prognostic factors for favorable outcome in disseminated germ cell tumorsR Birch, S Williams, A Cone, et al.
Oncology|January 1, 1992
Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancerF A Greco, P B Murphy, J D Hainsworth, et al.
American Journal of Clinical Oncology|October 1, 1990
The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP)J D Hainsworth, H W Jones, L S Burnett, et al.
Pageof 32

Showing results (201-210 of 313) with videos related to

Sort By:
Pageof 32
Clinical Pharmacology and Therapeutics|May 1, 1982
Effects of high-dose cytarabineK R Hande, R S Stein, D A McDonough, et al.
Cancer Treatment Reports|May 1, 1985
Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lungL L Porter, D H Johnson, J D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II studyD S Thompson, J D Hainsworth, K R Hande, et al.
Cancer Treatment Reports|October 1, 1983
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lungS N Wolff, D H Johnson, K R Hande, et al.
The American Journal of Medicine|September 1, 1982
Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancerK R Hande, R K Oldham, M F Fer, et al.
Cancer Treatment Reports|March 1, 1981
Combination of vinblastine and bleomycin in metastatic renal cell carcinomaJ A Knost, R K Oldham, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposideJ D Hainsworth, J B Erland, L A Kalman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Prognostic factors for favorable outcome in disseminated germ cell tumorsR Birch, S Williams, A Cone, et al.
Oncology|January 1, 1992
Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancerF A Greco, P B Murphy, J D Hainsworth, et al.
American Journal of Clinical Oncology|October 1, 1990
The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP)J D Hainsworth, H W Jones, L S Burnett, et al.
Pageof 32